Published in Biol Sex Differ on January 28, 2015
MicroRNAs and drug-induced kidney injury. Pharmacol Ther (2016) 0.86
Relationship of cell-free urine MicroRNA with lupus nephritis in children. Pediatr Rheumatol Online J (2016) 0.76
Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats. Food Chem Toxicol (2016) 0.75
Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biol Sex Differ (2017) 0.75
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update. J Womens Health (Larchmt) (2016) 0.75
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A (2009) 6.91
MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet (2012) 5.38
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect (2003) 3.39
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol (2008) 2.74
Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol (2008) 2.69
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ (2013) 2.41
Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A (2010) 2.31
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol (2011) 2.31
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2011) 2.27
Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med (2013) 1.98
Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest (2010) 1.90
Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.82
ArrayTrack: an FDA and public genomic tool. Methods Mol Biol (2009) 1.71
Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol (2012) 1.70
Gender and human chronic renal disease. Gend Med (2008) 1.59
The role of gender in the progression of renal disease. Adv Ren Replace Ther (2003) 1.57
Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos (2004) 1.31
Sex, diabetes and the kidney. Am J Physiol Renal Physiol (2009) 1.26
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med (2010) 1.25
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer (2013) 1.21
The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int (2013) 1.21
Cyclin D1 is a major target of miR-206 in cell differentiation and transformation. Cell Cycle (2013) 1.16
Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn (2011) 1.16
MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol (2013) 1.16
MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer (2013) 1.16
miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res (2014) 1.13
The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol (2004) 1.12
Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene (2013) 1.11
c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biol Chem (2004) 1.09
MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency. Am J Nephrol (2011) 1.08
Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem (2012) 1.07
Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics (2010) 1.05
miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. Biochem Biophys Res Commun (2013) 1.04
Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis. Am J Kidney Dis (2011) 1.03
MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03
Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ (2014) 1.00
MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis. Br J Cancer (2013) 0.99
Sex differences in kidney gene expression during the life cycle of F344 rats. Biol Sex Differ (2013) 0.99
MicroRNAs: new players in heart failure. Mol Biol Rep (2012) 0.97
Expression and function of microRNAs in heart disease. Curr Drug Targets (2010) 0.95
MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One (2013) 0.95
MicroRNAs in the kidney: novel biomarkers of acute kidney injury. Nefrologia (2013) 0.93
MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring. Nephrol Dial Transplant (2013) 0.90
MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis (2013) 0.90
Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases. Ther Clin Risk Manag (2014) 0.90
MicroRNAs and their implications in toxicological research. Toxicol Lett (2010) 0.89
Gender related differences in kidney injury induced by mercury. Int J Mol Sci (2012) 0.87
MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin. Toxicol Sci (2014) 0.87
MicroRNAs in Diabetic Kidney Disease. Int J Endocrinol (2014) 0.86
From cellular senescence to age-associated diseases: the miRNA connection. Longev Healthspan (2012) 0.85
Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study. Curr Clin Pharmacol (2009) 0.85
Gender difference following high cholesterol diet induced renal injury and the protective role of rutin and ascorbic acid combination in Wistar albino rats. Lipids Health Dis (2012) 0.83
Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol (2004) 0.83
Identification of an imprinted gene cluster in the X-inactivation center. PLoS One (2013) 0.82
MicroRNA regulation in renal pathophysiology. Int J Mol Sci (2013) 0.82
Metzincins and related genes in experimental renal ageing: towards a unifying fibrosis classifier across species. Nephrol Dial Transplant (2014) 0.81
MicroRNAs in kidney transplantation. Nephrol Dial Transplant (2014) 0.81
Chitosan induced hepato-nephrotoxicity in mice with special reference to gender effect in glycolytic enzymes activities. Regul Toxicol Pharmacol (2011) 0.81
Antagomirs and microRNA in status epilepticus. Epilepsia (2013) 0.80
The influence of sex on early stage markers of kidney dysfunction in response to juvenile obesity. Hypertension (2012) 0.79
Impact of gender on renal disease: the role of the renin angiotensin system. Clin Invest Med (2003) 0.79